Stock Events

Stock Events

Ab Science 

$1.45
32
+$0.05+3.57% Thursday 21:00

Statistics

Day High
2.7
Day Low
2.7
52W High
2.7
52W Low
1.2
Volume
1,452
Avg. Volume
26
Mkt Cap
83.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q1 2021
Q1 2021
Q1 2024
Q2 2024
Q1 2025
Q3 2025
Next
-0.21
-0.14
-0.07
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-731.12%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.24MRevenue
-16.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABSCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with AB Science in the development of treatments for various diseases, including those in oncology and inflammatory diseases, areas where AB Science is also active.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes across multiple segments, including those targeted by AB Science, such as cancer and chronic inflammatory diseases, with a broad portfolio of drugs.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech company focusing on human therapeutics, with products that compete in the oncology and inflammatory disease markets, directly competing with AB Science's research and drug development efforts.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a research-based biopharmaceutical company with a wide range of products that compete with AB Science, especially in the fields of oncology and immunology.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a healthcare company that competes with AB Science in developing treatments for various diseases, including cancer and chronic inflammatory conditions, through its biotechnology and pharmaceutical divisions.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with AB Science's portfolio, especially in cancer and immune-inflammatory diseases.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is known for its contributions to healthcare and pharmaceuticals, competing with AB Science in areas such as oncology, making it a direct competitor in the development of cancer treatments.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is a global pharmaceutical company that develops drugs in areas like oncology and autoimmune diseases, competing with AB Science in the development and marketing of treatments for similar conditions.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is a biotechnology company that competes with AB Science in the development of medicines for the treatment of serious medical conditions, including oncology and inflammatory diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of therapeutic products, competing with AB Science in areas such as oncology and respiratory diseases.

About

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Show more...
CEO
Mr. Alain Moussy MBA
Employees
40
Country
FR
ISIN
FR0010557264

Listings

PA
FR
ABBS.PA
PA
FR
ABSBS.PA
OTC Link
US
ABSCF
PA
FR
AB.PA

0 Comments

Share your thoughts

FAQ

What is Ab Science stock price today?▼
The current price of ABSCF is $1.45 USD — it has increased by +3.57% in the past 24 hours. Watch Ab Science stock price performance more closely on the chart.
What is Ab Science stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ab Science stocks are traded under the ticker ABSCF.
What is Ab Science market cap?▼
Today Ab Science has the market capitalization of 83.85M
When is the next Ab Science earnings date?▼
Ab Science is going to release the next earnings report on May 06, 2026.
What is Ab Science revenue for the last year?▼
Ab Science revenue for the last year amounts to 2.24M USD.
What is Ab Science net income for the last year?▼
ABSCF net income for the last year is -16.37M USD.
How many employees does Ab Science have?▼
As of April 03, 2026, the company has 40 employees.
In which sector is Ab Science located?▼
Ab Science operates in the Health Care sector.
When did Ab Science complete a stock split?▼
Ab Science has not had any recent stock splits.
Where is Ab Science headquartered?▼
Ab Science is headquartered in Paris, FR.